Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

(2020) Jingyuan Xie et al.   Nature Communications

Exostosin 1/Exostosin 2–Associated Membranous Nephropathy

(2019) Sanjeev Sethi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

(2019) Fernando C. Fervenza et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

(2019) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome

(2018) Alice Bonanni et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab

(2018) Anne-Els van de Logt et al.   KIDNEY INTERNATIONAL

Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy

(2017) Barbara Seitz-Polski et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy

(2017) Jan A.J.G. van den Brand et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A Proposal for a Serology-Based Approach to Membranous Nephropathy

(2016) An S. De Vriese et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

(2016) Karine Dahan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy

(2015) A. Thompson et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

(2015) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Antiphospholipase A2 Receptor Autoantibody Guided Diagnosis and Treatment of Membranous Nephropathy: A New Personalized Medical Approach

(2014) R. J. Glassock   Clinical Journal of the American Society of Nephrology

Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy

(2014) A. P. Bech et al.   Clinical Journal of the American Society of Nephrology

Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy

(2014) E. Hoxha et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

(2014) Nicola M. Tomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy

(2013) Cornelia Dähnrich et al.   CLINICA CHIMICA ACTA

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

(2013) Durga Kanigicherla et al.   KIDNEY INTERNATIONAL

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

(2013) Andrew Howman et al.   LANCET

Rituximab in Idiopathic Membranous Nephropathy

(2012) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy

(2011) L. H. Beck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy

(2011) W. Qin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE